NEW YORK (GenomeWeb News) – Caprotec Bioanalytics said today that it will collaborate with a division of Merck KGaA to identify protein and drug interactions using its mass spectrometry technology.
 
Under the agreement, Caprotec will use its Capture Compound Mass Spectrometry technology for a research project for Merck Serono. Berlin-based Caprotec will be paid research fees and milestone payments for product development, it said.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.